本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

46.11
+0.45000.99%
成交量:75.85万
成交额:3,487.02万
市值:87.55亿
市盈率:-13.04
高:46.24
开:45.61
低:45.27
收:45.66
数据加载中...
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

重要事件披露

8-K - Current report
2021/01/26

重要事件披露

8-K - Current report
2021/01/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

重要事件披露

8-K - Current report
2021/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/20

重要事件披露

8-K - Current report
2021/01/13

企业合并公告

425 - Prospectuses and communications, business combinations
2021/01/12

重要事件披露

8-K - Current report
2021/01/12

企业合并公告

425 - Prospectuses and communications, business combinations
2021/01/04

企业合并公告

425 - Prospectuses and communications, business combinations
2021/01/04

重要事件披露

8-K - Current report
2020/12/11

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/06

SEC问询函

CORRESP [Cover] - Correspondence